НовостиBenzingaGuggenheim Reiterates Buy on Oruka Therapeutics, Maintains $200 Price Target Guggenheim Reiterates Buy on Oruka Therapeutics, Maintains $200 Price Target Benzinga 2026.10.27 13:37 (GMT+0) Открыть на Benzinga Другие новости